IC
ABBV icon

IEQ Capital’s AbbVie ABBV Stock Holding History

IEQ Capital’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$35.4M Buy
102,081
+53,573
+110% +$11.5M 0.16% 114
2026
Q1 		$10.5M Sell
48,508
-77,309
-61% -$17.1M 0.05% 339
2025
Q4 		$28.7M Sell
125,817
-37,674
-23% -$8.58M 0.09% 140
2025
Q3 		$37.9M Buy
163,491
+43,456
+36% +$8.85M 0.11% 87
2025
Q2 		$22.3M Buy
120,035
+5,274
+5% +$980K 0.14% 113
2025
Q1 		$24M Buy
114,761
+38,156
+50% +$7.42M 0.19% 83
2024
Q4 		$13.6M Sell
76,605
-35,104
-31% -$6.45M 0.13% 99
2024
Q3 		$22.1M Buy
111,709
+7,153
+7% +$1.33M 0.27% 58
2024
Q2 		$17.9M Sell
104,556
-25,552
-20% -$4.23M 0.24% 60
2024
Q1 		$23.7M Buy
130,108
+40,467
+45% +$6.97M 0.34% 48
2023
Q4 		$13.9M Buy
89,641
+423
+0.5% +$61.7K 0.23% 65
2023
Q3 		$13.3M Buy
89,218
+8,860
+11% +$1.3M 0.27% 60
2023
Q2 		$10.8M Sell
80,358
-16,634
-17% -$2.44M 0.22% 74
2023
Q1 		$15.5M Sell
96,992
-3,192
-3% -$488K 0.36% 47
2022
Q4 		$16.2M Buy
100,184
+9,855
+11% +$1.51M 0.45% 40
2022
Q3 		$12.1M Buy
90,329
+10,415
+13% +$1.49M 0.33% 47
2022
Q2 		$12.2M Buy
79,914
+1,960
+3% +$299K 0.37% 49
2022
Q1 		$12.6M Buy
77,954
+10,278
+15% +$1.49M 0.3% 55
2021
Q4 		$9.16M Buy
67,676
+7,809
+13% +$922K 0.21% 66
2021
Q3 		$6.46M Buy
59,867
+3,022
+5% +$345K 0.17% 78
2021
Q2 		$6.4M Buy
56,845
+9,991
+21% +$1.13M 0.19% 74
2021
Q1 		$5.07M Buy
46,854
+2,245
+5% +$240K 0.21% 76
2020
Q4 		$4.78M Buy
44,609
+765
+2% +$73.5K 0.21% 80
2020
Q3 		$3.84M Sell
43,844
-4,480
-9% -$422K 0.21% 76
2020
Q2 		$4.74M Buy
48,324
+2,190
+5% +$193K 0.31% 58
2020
Q1 		$3.52M Buy
46,134
+41
+0.1% +$3.49K 0.28% 57
2019
Q4 		$4.08M Buy
+46,093
New +$3.83M 0.36% 42

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

IEQ Capital's ABBV Position: Q2 2026 in Review

IEQ Capital increased its AbbVie (ABBV) stake by 110% in Q2 2026, buying an estimated $11.5M and bringing the position to 102,081 shares worth $35.4M. The position accounts for 0.16% of the portfolio, ranked #114.

IEQ Capital first reported a position in ABBV in Q4 2019 and has held it in 27 quarters since. The position peaked at $37.9M in Q3 2025. 4,192 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • IEQ Capital held 102,081 shares of AbbVie worth $35.4M as of Q2 2026.
  • IEQ Capital bought 53,573 AbbVie shares in Q2 2026, an estimated $11.5M.
  • AbbVie made up 0.16% of IEQ Capital's portfolio in Q2 2026, its #114 holding.
  • IEQ Capital first reported a position in AbbVie in Q4 2019 and has held it in 27 quarters since.
  • IEQ Capital's AbbVie position peaked at $37.9M in Q3 2025.
  • 4,192 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on IEQ Capital's 13F filing for Q2 2026, filed 11 Aug 2026.